169 related articles for article (PubMed ID: 20348558)
1. A model for medication safety event detection.
Snyder RA; Fields W
Int J Qual Health Care; 2010 Jun; 22(3):179-86. PubMed ID: 20348558
[TBL] [Abstract][Full Text] [Related]
2. Development, testing, and findings of a pediatric-focused trigger tool to identify medication-related harm in US children's hospitals.
Takata GS; Mason W; Taketomo C; Logsdon T; Sharek PJ
Pediatrics; 2008 Apr; 121(4):e927-35. PubMed ID: 18381521
[TBL] [Abstract][Full Text] [Related]
3. Incidence, preventability, and impact of Adverse Drug Events (ADEs) and potential ADEs in hospitalized children in New Zealand: a prospective observational cohort study.
Kunac DL; Kennedy J; Austin N; Reith D
Paediatr Drugs; 2009; 11(2):153-60. PubMed ID: 19301935
[TBL] [Abstract][Full Text] [Related]
4. Identifying drug safety issues: from research to practice.
Gandhi TK; Seger DL; Bates DW
Int J Qual Health Care; 2000 Feb; 12(1):69-76. PubMed ID: 10733086
[TBL] [Abstract][Full Text] [Related]
5. Reevaluating the safety profile of pediatrics: a comparison of computerized adverse drug event surveillance and voluntary reporting in the pediatric environment.
Ferranti J; Horvath MM; Cozart H; Whitehurst J; Eckstrand J
Pediatrics; 2008 May; 121(5):e1201-7. PubMed ID: 18450863
[TBL] [Abstract][Full Text] [Related]
6. Adverse drug event detection in pediatric oncology and hematology patients: using medication triggers to identify patient harm in a specialized pediatric patient population.
Call RJ; Burlison JD; Robertson JJ; Scott JR; Baker DK; Rossi MG; Howard SC; Hoffman JM
J Pediatr; 2014 Sep; 165(3):447-52.e4. PubMed ID: 24768254
[TBL] [Abstract][Full Text] [Related]
7. Adverse drug events in older hospitalized patients: results and reliability of a comprehensive and structured identification strategy.
Klopotowska JE; Wierenga PC; Stuijt CC; Arisz L; Dijkgraaf MG; Kuks PF; Asscheman H; de Rooij SE; Lie-A-Huen L; Smorenburg SM;
PLoS One; 2013; 8(8):e71045. PubMed ID: 23940688
[TBL] [Abstract][Full Text] [Related]
8. Preventable and non-preventable adverse drug events in hospitalized patients: a prospective chart review in the Netherlands.
Dequito AB; Mol PG; van Doormaal JE; Zaal RJ; van den Bemt PM; Haaijer-Ruskamp FM; Kosterink JG
Drug Saf; 2011 Nov; 34(11):1089-100. PubMed ID: 21981436
[TBL] [Abstract][Full Text] [Related]
9. Medication safety program reduces adverse drug events in a community hospital.
Cohen MM; Kimmel NL; Benage MK; Cox MJ; Sanders N; Spence D; Chen J
Qual Saf Health Care; 2005 Jun; 14(3):169-74. PubMed ID: 15933311
[TBL] [Abstract][Full Text] [Related]
10. Adverse drug events among hospitalized Medicare patients: epidemiology and national estimates from a new approach to surveillance.
Classen DC; Jaser L; Budnitz DS
Jt Comm J Qual Patient Saf; 2010 Jan; 36(1):12-21. PubMed ID: 20112660
[TBL] [Abstract][Full Text] [Related]
11. Characterising the complexity of medication safety using a human factors approach: an observational study in two intensive care units.
Carayon P; Wetterneck TB; Cartmill R; Blosky MA; Brown R; Kim R; Kukreja S; Johnson M; Paris B; Wood KE; Walker J
BMJ Qual Saf; 2014 Jan; 23(1):56-65. PubMed ID: 24050986
[TBL] [Abstract][Full Text] [Related]
12. The epidemiology of preventable adverse drug events: a review of the literature.
von Laue NC; Schwappach DL; Koeck CM
Wien Klin Wochenschr; 2003 Jul; 115(12):407-15. PubMed ID: 12918183
[TBL] [Abstract][Full Text] [Related]
13. Analysis of medication-related triggers to determine adverse drug events.
Augustino M; Rowcliffe M; Feemster A; Smith J; Duncan R
Eur J Hosp Pharm; 2023 Mar; 30(2):92-95. PubMed ID: 35177534
[TBL] [Abstract][Full Text] [Related]
14. Improving drug safety in hospitals: a retrospective study on the potential of adverse drug events coded in routine data.
Kuklik N; Stausberg J; Amiri M; Jöckel KH
BMC Health Serv Res; 2019 Aug; 19(1):555. PubMed ID: 31395053
[TBL] [Abstract][Full Text] [Related]
15. Performance of the adverse drug event trigger tool and the global trigger tool for identifying adverse drug events: experience in a Belgian hospital.
Carnevali L; Krug B; Amant F; Van Pee D; Gérard V; de Béthune X; Spinewine A
Ann Pharmacother; 2013 Nov; 47(11):1414-9. PubMed ID: 24285758
[TBL] [Abstract][Full Text] [Related]
16. Adverse drug event trigger tool: a practical methodology for measuring medication related harm.
Rozich JD; Haraden CR; Resar RK
Qual Saf Health Care; 2003 Jun; 12(3):194-200. PubMed ID: 12792009
[TBL] [Abstract][Full Text] [Related]
17. A clinical pharmacist-led integrated approach for evaluation of medication errors among medical intensive care unit patients.
Aghili M; Neelathahalli Kasturirangan M
JBI Evid Implement; 2021 Mar; 19(1):21-30. PubMed ID: 33570331
[TBL] [Abstract][Full Text] [Related]
18. Strategies for detecting adverse drug events among older persons in the ambulatory setting.
Field TS; Gurwitz JH; Harrold LR; Rothschild JM; Debellis K; Seger AC; Fish LS; Garber L; Kelleher M; Bates DW
J Am Med Inform Assoc; 2004; 11(6):492-8. PubMed ID: 15299000
[TBL] [Abstract][Full Text] [Related]
19. Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group.
Bates DW; Cullen DJ; Laird N; Petersen LA; Small SD; Servi D; Laffel G; Sweitzer BJ; Shea BF; Hallisey R
JAMA; 1995 Jul; 274(1):29-34. PubMed ID: 7791255
[TBL] [Abstract][Full Text] [Related]
20. Preventable adverse drug events and their causes and contributing factors: the analysis of register data.
Jylhä V; Saranto K; Bates DW
Int J Qual Health Care; 2011 Apr; 23(2):187-97. PubMed ID: 21242162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
